AUTOMEDIX SCIENCES INC
8-K, 1996-12-06
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: MEDIZONE INTERNATIONAL INC, 8-K, 1996-12-06
Next: PUTNAM AMERICAN GOVERNMENT INCOME FUND, NSAR-B/A, 1996-12-06




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 Current Report
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934



      Date of Report (Date of Earliest Event Reported): November 21, 1996


                                   COMC, INC.
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)



           Illinois                     0-16472              36-3021754
- -------------------------------       ------------        ----------------------
(State or Other Jurisdiction of       (Commission         (I.R.S. Employer
Incorporation or Organization)        File Number)        Identification Number)




400 N. Glenoaks Boulevard, Burbank, California                          91502
- ----------------------------------------------                        ----------
(Address of Principal Executive Offices)                              (Zip Code)


Registrant's telephone number, including area code: (818) 556-3333
                                                    --------------   



Automedix Sciences, Inc.
2801 Barranca Parkway, Irvine, California 92714
- ------------------------------------------------------------
(Former Name or Former Address if Changed Since Last Report)




<PAGE>



Item 1.        Changes in Control of Registrant.

        On  November   21,   1996,   COMC,   Inc.,   an   Illinois   corporation
("Registrant"),  consummated  a share  exchange (the  "Exchange")  with Mr. John
Ackerman,  the sole  shareholder  of  Complete  Communications  Incorporated,  a
California  corporation  ("CCI").  Under the Exchange,  pursuant to an agreement
dated as of June 3, 1996,  Registrant acquired all issued and outstanding shares
of CCI in  consideration  for the  issuance to Mr.  Ackerman of an  aggregate of
10,000,000 shares of Common Stock of Registrant ("Common Stock").

        Under the  Exchange,  Mr.  Ackerman  is entitled to elect a new Board of
Directors. Messrs. Marvin Loeb, Richard Horowitz and Donald Baker have agreed to
remain  on the  Board.  Mr.  Ackerman  will  fill  the  vacancy  created  by the
resignation of Bruce Barron.

        The number of shares of Common Stock issued to Mr. Ackerman gives effect
to the reverse stock split described under Item 5. As a result,  Mr. Ackerman is
the  beneficial  owner of  10,000,000  shares of Common  Stock out of a total of
12,500,000  shares,  representing  approximately  80%.  In  connection  with the
Exchange, Registrant issued an aggregate of 625,000 shares of Common Stock to an
unaffiliated third party as a finder's fee.

        See Item 2. for additional disclosure.

Item 2.        Acquisition or Disposition of Assets.

        On November 21, 1996, Registrant  consummated the Exchange with Mr. John
Ackerman,  the sole shareholder of CCI. Under the Exchange,  Registrant acquired
all issued and outstanding  shares of CCI in  consideration  for the issuance to
Mr.  Ackerman  of an  aggregate  of  10,000,000  shares  of  Common  Stock.  The
transaction will be accounted for as a reverse acquisition.

        The  number  of  shares  of Common  Stock  issued  to Mr.  Ackerman  was
arbitrarily  determined by the parties and represents  approximately  80% of the
total  number of shares of Common Stock  outstanding  upon  consummation  of the
Exchange.

        See Item 1. for additional disclosure.

Item 5.        Other Events.

        In connection with the Exchange,  effective November 6, 1996, Registrant
amended its certificate of incorporation to (i) effectuate a one for ten reverse
stock split of all issued and  outstanding  shares of Common Stock,  (ii) change
its corporate name from Automedix  Sciences,  Inc. to COMC, Inc., (iii) increase
the number of shares of  Common Stock it is authorized to  issue from 20,000,000

                                              2

<PAGE>



shares to 40,000,000  shares, and (iv) eliminate its Class B Common Stock. Prior
to the  elimination  of the  Class B  Common  Stock,  all  Class B  Shares  were
converted  into  shares of Common  Stock on a one for one basis,  subject to the
reverse stock split.

Item 7.        Financial Statements, Pro Forma Financial Information and
               Exhibits.

        (a)           Financial Statements

        Financial  statements of businesses acquired will be filed in accordance
with the rules and regulations  promulgated under the Securities Exchange Act of
1934, as amended.

        (b)           Pro Forma Financial Information

        Pro forma  financial  information  will be filed in accordance  with the
rules and regulations  promulgated under the Securities Exchange Act of 1934, as
amended.

        (c)           Exhibits

               (1)    Letter Agreement between Registrant and Complete
               Communications Incorporated dated June 3, 1996*


 -----------------
        * Pursuant to Rule 12b-23 promulgated under the Securities  Exchange Act
of 1934,  as amended,  this  document is  incorporated  herein by  reference  to
Registrant's  Information  Statement  dated  October  15,  1996 (34 Act File No.
0-16472).


                                              3

<PAGE>



                                    SIGNATURE



        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant  has duly  caused  this  registration  statement  to be signed on its
behalf by the undersigned, thereto duly authorized.



Date: December 5, 1996



                                             COMC, INC.


                                             By: /s/
                                                 --------------
                                                 John Ackerman,
                                                 President



                                              4





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission